191 related articles for article (PubMed ID: 24819639)
1. Physicians' concerns towards prescription adherence and treatment effectiveness in the clinical management of actinic keratosis.
Peris K; Neri L; Fargnoli MC; Pellacani G
G Ital Dermatol Venereol; 2014 Apr; 149(2):193-8. PubMed ID: 24819639
[TBL] [Abstract][Full Text] [Related]
2. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
[TBL] [Abstract][Full Text] [Related]
3. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
[TBL] [Abstract][Full Text] [Related]
4. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
Berman B; Cohen DE; Amini S
Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
[TBL] [Abstract][Full Text] [Related]
5. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
7. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
8. Italian guidelines and therapeutic algorithm for actinic keratoses.
Rossi R; Calzavara-Pinton PG; Giannetti A; Peserico A; Santucci M; Vena GA; Lotti T
G Ital Dermatol Venereol; 2009 Dec; 144(6):713-23. PubMed ID: 19907409
[TBL] [Abstract][Full Text] [Related]
9. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
10. Treatment considerations in actinic keratosis.
Goldenberg G
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
[TBL] [Abstract][Full Text] [Related]
11. The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
Cerio R
J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022
[TBL] [Abstract][Full Text] [Related]
12. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
13. Physician perceptions and experience of current treatment in actinic keratosis.
Stockfleth E; Peris K; Guillen C; Cerio R; Basset-Seguin N; Foley P; Sanches J; Culshaw A; Erntoft S; Lebwohl M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):298-306. PubMed ID: 25065394
[TBL] [Abstract][Full Text] [Related]
14. Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.
Berry K; Butt M; Kirby JS
JAMA Dermatol; 2017 May; 153(5):421-426. PubMed ID: 28114674
[TBL] [Abstract][Full Text] [Related]
15. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
[TBL] [Abstract][Full Text] [Related]
17. Swiss clinical practice guidelines on field cancerization of the skin.
Hofbauer G; Anliker M; Boehncke WH; Brand C; Braun R; Gaide O; Hafner J; Hunger R; Itin P; Kaeuper G; Lautenschlager S; Mainetti C; Streit M
Swiss Med Wkly; 2014; 144():w14026. PubMed ID: 25539459
[TBL] [Abstract][Full Text] [Related]
18. Current issues in the management of actinic keratosis.
Ceilley RI; Jorizzo JL
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S28-38. PubMed ID: 23228304
[TBL] [Abstract][Full Text] [Related]
19. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
20. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
